Top Stock to Buy #5 – McKesson Corp. (MCK)
McKesson Corp. (NYSE:MCK) provides pharmaceutical supply management and information technologies. The company acquired US Oncology in December.
S&P estimates that MCK will earn $6.35 in 2011 versus $4.29 in 2010. The company is in a strong financial position with over $3.9 billion in cash and good cash flow. Of the 20 analysts covering MCK, 18 have either a “strong buy” or “buy” on the stock. And S&P targets the stock at $100.
Technically MCK has been consolidating around its 200-day moving average. A break above its May high of $88 should quickly propel it to our technical target of $105.